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ABSTRACT

The study of protein degradation mechanisms in neurons can advance our understanding of
multiple neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. Endoplasmic
reticulum-associated degradation (ERAD), plays an important role in reducing ER stress by
degrading accumulating misfolded proteins, which in turn prevents cell death. Many proteins
involved in ERAD are known, but the mechanisms themselves and roles of the proteins are not
yet fully understood. We use the nematode Caenorhabditis elegans as a model for studying
ERAD mechanisms. In particular our research focuses on the ubiquitin-proteasome system
(UPS) in ERAD. Ubiquitin-proteasome systems have the ability to modify proteins and target
them for degradation. Our goal is to help determine the relationship of the E2 and E3 ligase
proteins of ERAD in neurons by studying the regulation of the transmembrane olfactory receptor
ODR-10, in the AWA neurons of C. elegans. The ubiquitin pathway in ERAD involves multiple
ubiquitin ligases (E2s and E3s). The interactions between the E2 and E3 enzymes, and their
target specificity in the endoplasmic reticulum is not well understood in metazoan systems. Our
research highlights the role and interactions of the E2 and E3 proteins with regards to regulation
of ODR-10. We have analyzed the effects of loss of function mutations of E2 and E3 proteins to
determine their effects on localization, expression levels of ODR-10, and also behavioral
changes. Based upon this data we can make inferences of potential E2 and E3 protein
interactions. Researching ODR-10 ubiquitin regulation in ERAD will enable us to further
understand protein regulation in neurons. Through characterizing pathways that reduce cell
stress, such as ERAD, we may even gain insight as to potential limits or treatments of
neurodegenerative diseases.
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INTRODUCTION

Understanding normal cellular function in neurons will provide information about what
may be happening in at-risk individuals of neurodegenerative diseases. In particular, a clearer
understanding of protein degradation pathways, will allow us to further analyze causes for
diseases and define possible treatments. For instance, protein aggregation is known to lead to a
number of neurodegenerative disorders and other genetic diseases, such as Alzheimer’s and
Parkinson’s (Mittal et al., 2015). The cause of protein aggregation within neurodegenerative
diseases is not yet fully understood. Therefore, studying pathways that regulate protein
aggregation and reducing cell stress will be important in depicting what may be the underlying
causes to neurodegenerative disorders. As cells differentiate and specialize, a large volume of
specific proteins is necessary to carry out various functions. Protein and RNA alone can take up
as much as 40% of a cell’s entire volume (Mittal et al., 2015). With such high density, proteins
must maintain abundance within specific ranges to avoid overcrowding and potential protein
aggregation. If protein production and degradation are not balanced they cause cellular stress,
which can result in cell death and onset of neurodegeneration (Lee et al., 2015).

The secretory pathway and UPS

The ubiquitin-proteasome system (UPS), plays an important role in neurodegeneration
and regulating protein aggregation. When proteins involved in the UPS do not function properly,
they no longer regulate protein levels in neuronal cells and trigger cell death (Chung et al.,
2001). One pathway that requires close protein production regulation by the UPS is the secretory

pathway. In mammals an estimated one third of the genome encodes proteins destined for the
secretory pathway (Olzmann et al., 2013). The secretory pathway processes all proteins that will
be secreted from the cell or reside in the plasma membrane. During translation, transmembrane
or secretory proteins are transported to the endoplasmic reticulum (ER), then after completion of
translation and proper folding they are trafficked to the Golgi apparatus and ultimately are
exported to their final destinations (Cooper, 2000).
Within the secretory pathway, the UPS regulates protein degradation at the ER since this
organelle is one of the first to come into contact with misfolded or damaged proteins. The ER
serves as the primary gateway for the secretory pathway (Fewell et al., 2001). The main
functions of the ER are facilitating disulfide bond formation and ensuring proper topology during
protein folding (Fewell et al., 2001). This sizeable role requires the ER’s processing of proteins
to be highly regulated to ensure that the cell produces fully functional proteins at the necessary
levels. Before proteins are transported to the Golgi, multiple check points for misfolded,
damaged, and incomplete proteins are performed, this is known as ER quality control (ERQC)
(Vembar and Brodsky, 2008). In the ER lumen, a chaperone protein, BiP, binds to newly
translated polypeptides and chaperones the proper folding of the hydrophobic regions of proteins
(Rutledge et al., 2009). As part of regulation, BiP remains attached to improperly folded
hydrophobic regions and either retains them within the ER lumen or they are subsequently
degraded via ER stress response pathways (Cooper, 2000; Rutledge et al., 2009). This
mechanism prevents non-functional proteins from advancing through the secretory pathway,
which is considered toxic to the cell and can cause cell death.
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ER quality control

The two main mechanisms that collaborate in response to protein quality control at the
ER, the unfolded protein response (UPR) and endoplasmic reticulum-associated degradation
(ERAD), reduce ER stress and prevent cell death. The UPR is induced by aggregation of
misfolded or unassembled proteins within the ER lumen (Cao and Kaufman, 2012). The UPR
has distinct pathways relatively conserved among metazoans (Moore and Hollien, 2012). In
response to BiP’s remaining bound to misfolded proteins, the UPR initiates transcriptional
upregulatory and translational inhibitory mechanisms in an attempt to balance the amount of
protein degradation with the amount of protein production. Genes transcriptionally upregulated
by the UPR encode proteins that degrade mRNA localized at the ER to reduce translation
(Hollien and Weissman, 2006). With widespread translational inhibition, the uptake of
polypeptides into the ER lumen is also reduced (Harding et al., 2000). By inhibiting translation
and reducing the abundance of many mRNAs, the cell is able to manage the aggregated proteins
already accumulated within the ER without adding more protein to the cellular environment. The
UPR also upregulates transcriptional activation of genes involved in the secretory pathway and
protein degradation (Travers et al., 2000). By upregulating these proteins, the cell is able to
increase the processing and degradation of the proteins accumulated within the ER, reducing
stress.
ER-associated degradation (ERAD) is the second response that can occur from ER stress
and is the mechanism our study is focused upon (Figure1). Some genes associated with ERAD
are also transcriptionally activated through mechanisms involved in the unfolded protein
response (Travers et al., 2000). However, ERAD is capable of ensuring homoeostasis without the
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involvement of UPR (Shen et al., 2004). The ERAD pathway removes and induces degradation
of misfolded and unassembled proteins from the ER into the cytoplasm (Vembar and Brodsky,
2008). Once the targeted substrates are retained in the ER lumen by BiP, a number of proteins
direct the substrate target to the ER membrane to be retrotranslocated, or removed from the ER
lumen into the cytoplasm. The protein p97, also known as the velosin containing peptide (VCP),
is responsible for ATP-dependent retrotranslocation and interacts with the ubiquitin-proteasome
system pathway of ERAD (Ye et al., 2005).

The ubiquitin-proteasome system of ERAD

Once misfolded proteins are at the membrane of the ER, E2 ubiquitin ligases and E3
ubiquitin ligases residing in the ER membrane mark the proteins for degradation via the
ubiquitin-proteasome system. Ubiquitination occurs in a four step process and often results in
recognition for degradation by the 26S proteasome in the cytosol (Ciechanover and Masucci,
2002; Papaevgeniou and Chondrogianni, 2014). 1) The E1 ubiquitin activating enzyme
adenylates the C-terminal glycine residue in ubiquitin, in turn “activating” the glycine residue.
The E1 protein then binds to the activated glycine protein by forming a thioester bond with the
catalytic cysteine site of the E1 protein. 2) E1 proteins then transfer the activated ubiquitin to
ubiquitin carrying E2 ligases, which create another thioester bond with the glycine in the
activated ubiquitin by a conserved catalytic cysteine in the E2 protein. 3) The E2 protein then
binds to an E3 ubiquitin protein ligase that is bound to the targeted substrate of interest. E2
proteins then modify the substrate with ubiquitin while the substrate is still bound to the E3
ligase. The ubiquitin modifier if covalently linked via its C-terminal glycine residue to a lysine
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residue on the substrate forming an isopeptide bond. 4) This cycle is repeated, linking ubiquitin
to lysines on the previously added ubiquitin to create a polyubiquitin chain on the substrate
protein. Depending on the number of ubiquitin molecules and their location on a target
substrate, adaptor proteins associated with the 26S proteasome in the cytoplasm recognize the
protein as marked for degradation.
There are dedicated E3 ligases and E2 proteins for ERAD, which have been, to date,
primarily studied in yeast. Genetic and biochemical analyses identify two pathways, involving
different E3 ligase proteins, which carry out substrate targeting. One involves the E3 ligase Hrd1
(HRD-1 is a homolog and HRDL-1 is a paralog in C. elegans), which resides within the ER
membrane and catalyzes ubiquitination of ERAD substrates in the ER lumen and ER membrane
(Sasagawa et al., 2007). The other is a complex containing the Doa10 E3 ligase (the C. elegans
ortholog is MARC-6), which also resides in the ER membrane and catalyzes ubiquitination of
ERAD substrates in the cytosol and nucleoplasm (Deng and Hochstrasser, 2006). Doa10 also
targets some ER transmembrane proteins as well (Habeck et al., 2015; Zattas et al., 2016). The
E2 proteins associated with the three E3 ligases in ERAD are known, and in some cases have
specific to which E3 ligases with which they interact. The E2 protein Ubc7 associates with E3
ligases Doa10 and Hrd1 (Cohen et al., 2015). Hrd1 also associates with E2 protein Ubc6 (Araki
and Nagata, 2011). The E3 ligase HRDL-1, in C. elegans, interacts with E2 protein UBC-6
(Hirsch et al., 2009). These E2 proteins bind to the appropriate E3 ligase and polyubiquitinate the
target substrate. Once ubiquitinated, ERAD substrates are recognized and degraded in the
cytoplasm by the 26S proteasome. Further research will determine if this pathway is also
represented in multicellular organisms, such as C. elegans and mammals.
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Another more recent yeast biochemical analysis provides insight to a different ubiquitin
pathway in ERAD. In this case, the E2 proteins, Ubc6 and Ubc7, work in tandem to create the
ubiquitin chain on a target substrate. Ubc6 first binds to the E3 ligase-target substrate complex
and attaches the first ubiquitin (Weber et al., 2016). Then, Ubc7 binds to the E3 ligase-target
substrate complex and polyubiquitinates the target substrate, creating the ubiquitin chain (Weber
et al., 2016). Finally, once the target substrate is polyubiquitinated at the ER membrane, it is
moved into the cytoplasm where it can be degraded by the 26S proteasome.
Biochemical analyses in yeast provide clues as to how the ubiquitin pathway regulates
misfolded proteins within ERAD. The question remains if the E2 proteins are specific for which
E3 ligase they can interact with, if they work in tandem and interact with all E3 ligases, or if a
combination of both mechanisms exists. Our interest is in determining if these mechanisms are
also present within multicellular organisms, in which there are few studies. Human homologs of
the E2 and E3 ligase proteins have been identified, but it is unknown if these homologs function
in the same manner as their yeast counterparts (Burr et al., 2011; Sasagawa et al., 2007). The E3
ligases in yeast are specific for what they target in terms of luminal vs. cytoplasmic substrates
(Huyer et al., 2004). However, it is not understood how, and if, all substrates are selectively
targeted and if chaperone proteins are always involved as seen by some substrates targeted by
Doa10 in yeast (Huyer et al., 2004; Shiber et al., 2013). There are situations where substrates are
targeted by both E3 ligases in yeast and the E3 ligases do not show specific selectivity (Huyer et
al., 2004).
Yeast is a unicellular organism, and these studies can only provide insight into how
ERAD functions in individual, uniform cells. In multicellular organisms, it is not fully
understood if ERAD functions the same in all cell types or if expression of E2 and E3 ligase
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proteins varies from cell to cell. Multicellular organisms also tend to have more E2 and E3 ligase
proteins involved in ERAD than yeast (Sasagawa et al., 2007; Tamura et al., 2010). Very little is
known about the ERAD mechanism in neurons of multicellular organisms and if the E3 ligases
display similar selective targeting of sensory receptors. Multicellular organisms also contain
more E3 ligases and E2 proteins than yeast, so these proteins may display more specific roles
towards the substrates they target compared to their yeast counterparts.

The model organism C. elegans

Our lab uses C. elegans as the model organism because their genome has been fully
sequenced and their nervous system is completely mapped. C. elegans neurons are not as
complex as other metazoa yet retain similar neuronal organization. The position and fate of every
cell in C. elegans has also been mapped, giving us ample information about cellular interactions.
C. elegans are optically clear, which is important for in vivo imaging. About 30% of genes
within C. elegans are highly conserved in humans, which makes them good models for studying
our genes of interest in higher organisms (Kaletta and Hengartner, 2006).

The odorant receptor ODR-10

To gain more insight on ERAD’s regulation of membrane proteins, we chose the Odorant
Receptor-10 (ODR-10) as the protein of interest in our study. ODR-10 is a transmembrane
receptor expressed specifically in the AWA neuron in C. elegans (Scholey, 2007). Within the
amphid sensilla chemosensory organs of C. elegans are two amphid wing cilia neurons termed
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AWA. The AWA cell bodies begin laterally in the head, and extend and terminate around the
mouth in a branched formation (Bargmann, 2006). The ODR-10 protein localizes only in the
membranes of the cilia of the AWA neurons in a normal animal (Sengupta et al., 1996). Due to
the small number of AWA neurons and the specificity of ODR-10 expression, this sensory
receptor can be studied in a small, focused region. This receptor also specifically binds to the
chemoattractant, diacetyl, a byproduct of bacteria, which C. elegans consume (Chuang and
Collins, 1968; Sengupta et al., 1996). There are no previous studies on ERAD regulation of
ODR-10, therefore our study may provide new insights into neuronal ERAD mechanisms and
olfactory regulation. Transgenic worms expressing ODR-10::GFP are readily available and make
it a perfect candidate.
Importantly, mutations in ERAD are associated as a possible cause of neurodegeneration
via ER-stress induced neuron cell death, such as in Alzheimer’s and Parkinson’s diseases
(Zeeshan et al., 2016). Interestingly, the loss of olfactory sensation is one of the first biomarkers
indicating early onset of neurodegenerative diseases (Cheng et al., 2011; Haehner et al., 2007).
Little is known how olfaction declines. Misregulated olfactory receptors or the general decline in
the function of neurons responsible for olfaction may both play roles. Our studies may shed light
on how a basic cellular pathway could help protect neurons from processes that precede
neurodegeneration and disease.
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Significance

This study adds to our knowledge about ERAD regulation and its regulatory effects on
transmembrane proteins within multicellular organisms. Through our study, we have also gained
insight on sensory receptor regulation and behavioral effects caused by mutations in the ERAD
ubiquitination pathway. There is still little known about the mechanism of E2 and E3 ligase
interactions within organisms and also across organisms. Understanding how the E2 and E3
ligase proteins interact is essential to understand what substrates are maintained under different
interactions within ERAD. If specific E2 or E3 proteins are no longer present we need to
understand what type of proteins and which proteins may be misregulated as a result.
Our findings could help determine possible treatments and even prevention of certain
degenerative symptoms. A recent study demonstrates the E3 ubiquitin ligase HRD-1 is capable
of reducing ER stress and preventing apoptosis when introduced into an Alzheimer’s model
organism and Parkinson’s model organism (Kaneko, 2012). HRD-1 is directly regulating
proteins linked to be responsible for onset of neurodegeneration in Alzheimer’s and Parkinson’s
patients (Kaneko, 2012; Zeeshan et al., 2016). Based on this finding a treatment could possibly
be developed to incorporate more HRD-1 and other E3 ligases like it into neurons to reduce
degeneration. It is possible other E3 ligases involved in ERAD may also be responsible for
regulating proteins that induce symptoms of neurodegenerative diseases. This further underlines
the importance of understanding protein degradation pathways, such as ERAD, in relation to
neurodegenerative diseases.
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Questions and Hypotheses

Are olfactory recptors regulated by ERAD?

Our overall question addresses whether or not olfactory receptors are regulated by an
ERAD mechanism. No studies have demonstrated a direct link between olfactory regulation and
ERAD. However, olfactory receptors are transmembrane proteins, which are subjected to go
through the secretory pathway, and therefore through the ER, the site of ERAD. We are not
going to study all olfactory receptors, but we need one representative candidate. ODR-10 works
well as that candidate. The possibility of ODR-10 being subjected to ERAD regulation is high
due to being present and folded at the site where ERAD regulates for misfolded proteins. We
hypothesize that if ODR-10 protein maintenance is regulated at the ER then ODR-10 is subjected
to ERAD regulation.
1) Is ODR-10 regulated by an ERAD mechanism that involves the known ubiquitin
pathways? We set three specific aims to address our central question. Our first aim is directed at
the ubiquitin pathway in ERAD. We hypothesize that if ODR-10 maintenance is affected by loss
of E3 ligase proteins then there is a specific ERAD mechanism targeting misfolded ODR-10.
The relationships between the E2 and E3 proteins involved in ERAD in C. elegans have been
characterized to an extent (Sasagawa et al., 2007). However, it is still unknown if both E2
proteins, UBC-6 and UBC-7, are required to work in tandem to ubiquitinate a target substrate or
if they work separately and are specific for which E3 ligase they will interact with. We have
demonstrated possible interactions by mutating the E2 and E3 ligase proteins involved in ERAD
and testing whether these mutations affect ODR-10 expression and/or localization. Since most
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studies of ERAD do point to an ubiquitin pathway it is not surprising to find a localization effect
on ODR-10, but we have found a broad variation of localization effects depending on which E2
or E3 protein is mutated.
2) Do the E3 ligases selectively target ODR-10? Misfolded sensory receptor targeting
by either specific or all E3 ligases in C. elegans is also unknown. Our second aim addresses
whether or not the E3 ligases selectively target ODR-10. We hypothesize that if we see varying
effects by loss-of-function mutations in the E3 proteins on ODR-10 expression, then there is an
E3 ligase that targets ODR-10 in the ubiquitin mechanism. We addressed this question by first
discerning if any of the E3 ligases involved in ERAD, HRD-1, HRDL-1, or MARC-6, affect
ODR-10 expression. After observing localization effects of ODR-10::GFP, we determined the
extent to which each E3 ligase effects ODR-10 localization and abundance at the cilia. All E3
ligases show some type of effect on ODR-10 localization, however some more than others.
3) Is one E2 protein sufficient for proper regulation of ODR-10 or are both
required? In one model based on research in yeast, each E3 ligase has a specific E2 protein with
which it interacts in the ERAD pathway. An alternative yeast model suggests both UBC-6 and
UBC-7 are required to create a polyubiquitin chain. Our third specific aim addresses whether a
single E2 protein is sufficient for regulation of ODR-10. We identified the localization effects of
each E3 ligase and in turn determined the effects of putative loss-of-function mutations in the E2
proteins. Based on my findings we determined that both putative loss-of-function E2 mutations
had an effect on ODR-10::GFP localization. Mutations in UBC-6 and UBC-7 resulted in
mislocalization effects and abundance at the cilia. This may suggest that both E2 proteins must
be functional in order to properly regulate misfolded ODR-10 or that one specific E2 protein is
interacting with a specific E3 ligase. Based on the information we gathered with the additional
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E3 mutational effects we can determine a potential ERAD ubiquitination mechanism regulating
ODR-10.

Are there changes in ODR-10-dependent behavior in the presence of ERAD mutations?

We observed localization defects and changes in abundance of ODR-10::GFP when
mutations were introduced in both E2 and E3 proteins of ERAD. Based on qualitative and
quantitative analysis, there is an increase in ODR-10::GFP ciliary fluorescence in the ERAD
mutant animals in addition to the mislocalization. Therefore, our second main question addresses
whether changes in ODR-10 abundance and localization in animals that harbor mutations in
ERAD genes also have changes in ODR-10-dependent behavior. We hypothesize that if
deficiencies in ERAD genes are causing an increase in ODR-10::GFP abundance then the
behavioral phenotype of chemotaxis will be impaired. The increase in fluorescence suggests that
increased levels of ODR-10 - either functional or damaged protein - is escaping the ER and
making its way to the cilia. If either cause is the case, it is possible either could be impairing
chemoattraction by too much functional protein or too little functional protein. We addressed this
question by performing chemotaxis assays to the attraction of diacetyl, the ligand of ODR-10.
Interestingly, we observed the E2 and E3 mutant animals portray varying effects in
chemoattraction.
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Are UBC-6 and UBC-7 localized at the ER in the AWA neuron?

In addition to addressing the ERAD ubiquitin pathway within C. elegans, we wanted to
characterize UBC-6 and UBC-7 in C. elegans, specifically in the AWA neurons. It is not known
if both E2 proteins are expressed in the AWA neurons, and if they are where they localize. We
addressed the question: Are UBC-6 and UBC-7 localized at the ER in the AWA neuron? We
hypothesize that if the E2 proteins are expressed in the AWA neuron then they are localized at
the ER, and possibly within the ER membrane, as observed in yeast (Boban et al., 2014; Deng
and Hochstrasser, 2006). To address this question we engineered transgenic animals containing
the E2 protein coding sequence fused with GFP downstream of the odr-10 promoter to track the
localization of these proteins within the AWA neurons.
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METHODS
C. elegans husbandry and strains

All C. elegans strains were derived from the wild type Bristol strain N2. Strains were
grown at 20°C on nematode growth medium in 60mm plates. The E. coli strain OP-50 was used
to feed the worms in all experiments. See Table 1 for a list of alleles and transgenic strains used
in this study.

Qualitatively Observing ODR-10::GFP localization in E2 and E3 mutants

Engineering the E2 and E3 mutant hybrids

To determine if ODR-10 expression is affected by mutations in the E2 and E3 proteins
involved in ERAD, we bred hybrids strains of E2 and E3 mutants expressing a reporter gene for
ODR-10 localization. The strain with an integrated sequence of odr-10 promoter driving ODR10 attached to GFP (Podr-10::ODR-10::GFP) (CX3344 kyIs53). To introduce E2 and E3 mutants
in the ODR-10::GFP background, we crossed the mutants into the CX3344 kyIs53 strain. The
Dahlberg lab also had access to the Million Mutation Project (MMP) kit. This kit contains 2,007
mutation strains of C. elegans and all alleles have been fully sequenced. Through this kit we
identified alleles expected to confer loss of function or knock out mutations in the E2 and E3
genes of interest.
E3 Mutations. The hrdl-1 and hrd-1 alleles, (gk28 and tm1743 respectively), are
considered loss of function mutations with large regions deleted near the N-terminus (Table 1 &
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Figure 2). The marc-6 strain VC20284 (gk121407), is a nonsense mutation corresponding to
W391stop (Table 1 & Figure 2). This premature stop is uncharacterized but a putative loss of
function allele due to loss of the transmembrane domain near the C-terminus.
E2 Mutations. ubc-6 and ubc-7 alleles are part of the MMP kit, and all strains are single
nucleotide polymorphisms that cause a missense mutation in the protein. Some of these strains
have a missense mutation in the ubiquitin conjugating catalytic (UBCc) domain. This domain in
the E2 protein is responsible for binding to ubiquitin proteins and interacting with E3 ligases
(Baptista et al., 2012). Because it is highly conserved across taxa, a mutation in the UBCc
domain or to helical bundles that may play a role in maintaining UBCc folding has a higher
chance of producing a loss of function allele. The ubc-6 strain VC20545 (gk146975) contains a
missense mutation at T158I (Table 1 & Figure 3). This mutation from threonine to isoleucine is
nonconservative and within the C-terminal helical bundle (Unpublished work, T. Ritterhoff)
directly downstream of the UBCc domain (Figure 3 & 6). This nonconservative mutation could
cause a conformation change blocking the site for interaction with E3 ligases. The chosen ubc-7
strain VC40870 (gk857464) contains a missense mutation at P79L (Table 1 & Figure 6). This
proline is highly conserved across taxa and is only 8 amino acids from the catalytic cysteine
(Figure 4). The nonconservative mutation from proline to leucine may cause structural change in
the protein causing the catalytic cysteine to be unable to interact with ubiquitin.
Mutant crossing. E2 and E3 mutant hermaphrodites were crossed with male CX3344
(kyIs53) worms. The ODR-10::GFP allele is on the X chromosome, therefore using carrier males
will produce heterozygous hermaphrodites. Once offspring were produced by the E2 or E3
mutant hermaphrodite, the presence of male offspring also indicates a successful cross with the
male carriers. Hermaphrodite offspring were then individually picked and transferred to new
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plates. These offspring (F1 generation) are all heterozygous for the mutant allele and ODR10::GFP. Once F2 offspring were produced by each F1 parent, the F1 parent was lysed and
reconfirmed as being a carrier of ODR-10::GFP through PCR, using the LD5 forward and LD4
reverse primers which amplify the beginning of the coding sequence of ODR-10 and ends after
the GFP coding sequence (Figure 2). Worm lysis is performed by combining lysis buffer and
Proteinase-k (PK) (1µl 20mg/ml PK per 100µl lysis buffer). 1µl of the lysis solution is used per
individual worm and undergo lysis in the thermocycler at 65°C for 45 minutes, and 95°C for 15
minutes. Worm lysis is then ready to use for PCR. The F2 offspring from carrier F1 parents were
then transferred to plates, individually. Some F2 offspring were homozygous for both the mutant
allele and ODR-10::GFP. Once offspring were produced by the F2 parents, the parents were
lysed and the DNA region surrounding the mutant allele is amplified via PCR, using their
respective primers for amplification (Table 2). hrd-1, hrdl-1, and marc-6 mutations can be
determined based on PCR products and gel electrophoresis. hrd-1 detection requires a one-step
PCR and hrdl-1 detection requires a two-step PCR. marc-6 detection uses a two-step PCR
technique followed by a restriction digest with the restriction enzyme EarI. For ubc-6 and ubc-7,
the amplified sequence via PCR was sent off for sequencing (MCLABs) in order to determine if
the parent was homozygous for the mutant allele by observing the substitution point mutation
locations. Parents that were confirmed mutant homozygotes were screened for ODR-10::GFP
homozygosity. This was done by lysing 8 individual F3 offspring per plate and then screening
for ODR-10::GFP presence via PCR as described above. If all 8 offspring show a band for ODR10::GFP, then that plate is homozygous for ODR-10::GFP. If no plates were homozygous for
either allele or just one, offspring were individually picked again and then rescreened until a
homozygous line was found.
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Fluorescent imaging

Once mutant crosses were made with E2 and E3 mutations, we imaged the crosses to
determine changes in ODR-10::GFP expression and localization in comparison to wild type and
between alleles. The level and localization of fluorescent-tagged ODR-10::GFP was first
analyzed qualitatively. A Leica DMi6000 fluorescent microscope, HCX PL FLUOTAR
40X/0.60 CORR PH2 objective, and Leica DFC3000 G camera were used to image the
fluorescence expression patterns. The GFP fluorescence filter was used and images were taken at
400X (total magnification), exposure time at 1 second, gain at 4, and camera acquisition at 12
bit. Adult gravid animals were randomly chosen from plates that were not starved or
overcrowded. Plates were usually 4 days old. Images were taken as Z stacks beginning at the top
of the worm where cilia fluorescence began to focus, and ending at the bottom of the worm
where cilia fluorescence began to fade again, the point where cilia fluorescence was no longer in
focus. 10 images in the Z-plane were taken for each worm. Z stacks were adjusted to include all
visible fluorescence present in the head of the worm, from cell body region to nose. Z stacks
were combined into one image using Z Project by maximum intensity projection using ImageJ.

Quantitatively analyzing ODR-10::GFP fluorescence

For quantifying fluorescence, 20 gravid animals per strain were chosen and imaged as
described above. To determine fluorescence levels over the distance of the line, the Plot Profile
tool within Analyze was used. Background fluorescence was then determined by observing the
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intensity levels in the non-fluorescent section of the worm; the line would typically level out at a
certain intensity. The determined background intensity was then used for all values of that worm.
Ciliary fluorescence was quantified by tracing individual cilia within the animal using the
segmented line tool, and line width was adjusted to include all fluorescence on that particular
cilium. Using the Plot Profile tool, a list of intensities over distance of the line is listed. The
distance, adjusted intensity, and background intensity values were used within the Shiny
program. The Shiny program then provides the value of the area under the line of intensity over
distance, this value is our total fluorescence intensity for that animal. To quantify multiple
branches of cilia within one animal, multiple segmented lines were concatenated. The distance of
the lines were added in sequence (adding the distance of the next line with the first line’s
distance to make a continuous distance measurement) to include the total fluorescence of all
ciliary branches within the animal. To make distance continuous the first data point, a distance of
0, in the successive lines is removed. Once fluorescence quantification was collected we used
Tukey’s HSD statistical analysis, run in R, to test for significant differences between strains.

Behavioral chemotaxis assay for phenotypic differences in E2 and E3 mutants

Chemotaxis assays were prepared on 100mm plastic plates filled with approximately 9ml
of 2% agar with salts: MgCl2, KPO4, and CaCl2. Plates were evenly divided into three sections:
left, middle, and right. A start marker was placed approximately one inch from the bottom of the
plate in the middle of the middle section, markers for placing 0.1% diacetyl and 95% ethanol
were placed at the apex of the curve on the furthest edge opposite each other in the left and right
sections. 1µl of 0.2% azide, a paralytic, is placed at the diacetyl/ethanol markers first. At the left
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marker, 1µl of 0.1% diacetyl (diluted 1:1000 in 95% ethanol) was placed over the spot of azide.
At the right marker, 1µl of 95% ethanol was placed over the spot of azide. Worms were prepared
4 days prior by bleaching 40-50 gravid adults on seeded 60mm plates, 2 plates per strain.
Bleaching solution contained 100µl water, 400µl 5N NaOH, and 500µl bleach per 1ml of
solution. Worms were then washed off the plates with M9 solution. Every 3 minutes 1ml M9 was
removed from the washed worms solution and 1ml of new M9 is added. Washes were repeated
for a total of four times. After worms were washed, approximately 150 worms (about 5.5µl of
washed worm solution) were placed on the 100mm plate at the start marker and left for two
hours. Any residual M9 placed on the 100mm plate when adding the washed worms was
removed with a kimwipe. After two hours worms were counted in five distinct locations: (A)
paralyzed at the diacetyl spot, (B) within the left (diacetyl) region but not paralyzed, (C) in the
middle region, (D) within the right (ethanol) region but not paralyzed, (E) and paralyzed at the
ethanol spot. A chemotaxis index was then calculated using the equation: (A-E) /
(A+B+C+D+E). A minimum of 10 chemotaxis assays per strain was performed. Chemotaxis
index scores were then analyzed through Tukey’s HSD statistical analysis, in R, to compare
differences between all strains and wild type.

Characterizing the E2 proteins, UBC-6 and UBC-7, in the AWA neuron

Engineering plasmids for promoter analysis of the E2 ubiquitin carrying proteins

Amplifying the E2 promoter regions. To observe E2 transcriptional activity in the
AWA neuron, we created plasmids containing the ubc-6 or ubc-7 promoter region upstream of
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GFP. We designed primers to amplify the promoter regions of ubc-6 and ubc-7 with restriction
sites BamHI (5’ end) and HindIII (3’ end) included on the ends of the amplified regions (Table
3). Promoter regions were amplified via PrimeStar PCR, and then purified by a gel DNA
extraction kit by ThermoFisher.
Creating the E2 promoter reporter plasmids. A preexisting plasmid containing the
odr-10 promoter upstream of GFP (pOdr-10::GFP) containing ampicillin resistance, was used as
the parent plasmid for reporter construct engineering. Restriction enzyme recognition sites
BamHI (5’ end) and HindIII (3’end) flank the odr-10 promoter region within the plasmid. The
parent plasmid was cut at these sites using a restriction enzyme digest with BamHI and HindIII
restriction enzymes at 37 degrees Celsius. The cut parent plasmid was then purified via the
Thermofisher DNA gel extraction kit. The amplified E2 promoter regions, described previously,
were then placed in the cut vector via ligation (Figure 6). Competent DH5α E. coli cells were
then transformed with the newly made plasmid via heat shock transformation. Transformed cells
were plated on Luria Broth plates with ampicillin and successful transformations were screened
via ampicillin resistance. Surviving colonies were then picked and screened via PCR, using the
E2 promoter primers, to determine the correct promoter insert was applied to the plasmid.
Colonies with correct insert were then picked and DNA was isolated via a Qiagen Plasmid Miniprep kit. Isolated DNA was then sequenced at MCLABs to determine if any mutations occurred
during amplification. Successful plasmids were then used to create transgenic animals.
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Engineering plasmids for in vivo protein localization analysis.

To determine localization patterns of UBC-6 and UBC-7 in the AWA neuron we created
plasmids containing GFP fluorescent-tagged ubc-6 and ubc-7 coding sequences. The plasmid
containing Podr-10::GFP was used and coding sequences of ubc-6 and ubc-7 were inserted
downstream of the odr-10 promoter. ODR-10 is specifically expressed in the AWA neuron and
we hoped to contain UBC-6/7 fluorescent expression to this neuron by utilizing the odr-10
promoter. We designed primers to amplify the coding sequences of the E2 genes. Two different
sets of primers were designed (Table 4): 1) A primer set that will insert the open reading frames
of the E2 genes upstream of GFP and downstream of the odr-10 promoter. 2) A primer set that
will allow GFP to be inserted upstream of the ubc-7 open reading frame and directly after the
start codon downstream of the Odr-10 promoter. Protein domains in UBC-6 and UBC-7 indicate
the C-terminus may be important as highly conserved domains are present near this region
(Marchler-Bauer et al., 2015). To account for this, plasmids were designed so that GFP could be
inserted either upstream or downstream of the open reading frame. The designed primers include
KpnI restriction sites on both ends on the coding sequences. A single KpnI restriction site was
located downstream of the odr-10 promoter and upstream of the GFP coding sequence in the
plasmid. Amplified coding sequences were inserted into the plasmid at this location by
restriction enzyme digest and ligations (Figure 7). Competent DH5α cells were transformed with
the plasmids containing the coding sequence inserts. Successful transformations were screened
by selective pressure to ampicillin resistance provided by the introduced plasmid. Surviving
colonies were picked and screened by directional PCR to determine if the correct insert was
obtained. Colonies that contained the correct insert were selected and DNA extracted via column
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purification. Isolated DNA was amplified by the corresponding primers and sequenced via the
company MCLABs to determine there are no underlying mutations within the sequence.

Generating transgenic worms for UBC-6 and UBC-7 GFP expression of protein
localization.

The created plasmids containing either the E2 coding sequence were then injected into
wild type C. elegans. Plasmid DNA was introduced into the germline of animals using injection
courtesy of the Ailion Lab at the University of Washington and Dr. Lina Dahlberg. Transgenic
animals were co-injected with the reporter construct Pttx-3::dsRed for screening successful
uptake of the DNA. Promising lines are stored at -80° Celsius.
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RESULTS
Regulation of ODR-10 by ERAD
To address whether ODR-10 is regulated by ERAD, putative loss-of-function mutations
in the E3 ligases, HRD-1, HRDL-1, and MARC-6, were crossed into animals containing
integrated ODR-10::GFP. Because ERAD does regulate secretory pathway substrates, the E3
ligases should be able to target any misfolded substrate regulated within the ER. Therefore, at
least one E3 ligase mutation should result in a localization defect for ODR-10::GFP if ODR-10
regulated by ERAD ubiquitination. Initially, we determined that there was mislocalization
consistently in the hrdl-1 animals; we therefore we went forward with screening all three E3
ligase putative knockouts. The E2 mutants were also not available as putative knock out alleles.
Therefore in the absence for a strong candidate for a null-allele in the E2 genes, it was logical to
begin studies with the E3 mutants.
The HRD-1 mutation (tm1743) is a 473bp deletion and subsequent 38bp insertion (Figure
2). This deletion results in the removal of the second half of exon 1 and almost all of exon 2
(Figure 2). Due to such a large region of the hrd-1 gene removed, hrd-1 is most likely a null
allele, resulting in no functional protein product. The HRDL-1 putative loss-of-function mutation
(gk28) is a 1981bp deletion that results in the removal of 5 of the 6 exons from the hrdl-1 coding
sequence (Figure 2). This large deletion also most likely causes a loss-of-function mutation
because most of the protein sequence has been removed. MARC-6 is known to target cytosolic
and nucleoplasmic proteins, therefore substrates targeted by MARC-6 should differ to HRD-1
and HRDL-1 targets (Sasagawa et al., 2007). We expected if HRD-1 and HRDL-1 effected
ODR-10::GFP localization, then MARC-6 may not have an effect as it may not target the same
substrates as HRD-1 and HRDL-1. However, this is not always the case. Doa10, the homolog of
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MARC-6, targets Ste6*, a multispanning transmembrane protein with a cytosolic mutation. But,
Ste6* can also be targeted by Hrd1, the homolog of HRD-1 (Huyer et al., 2004). In yeast, the TD
domain and CTE domain of Doa10 are responsible for substrate interaction and specific targeting
(Zattas et al., 2016). These domains are located in exons 5-8, which are no longer present in the
marc-6 (gk121407) mutant (Figure 2). Removal of the TD and CTE domains should result in a
loss of interaction with target substrates and therefore loss of function of MARC-6.
To determine if the E3 mutant alleles crossed in the ODR-10::GFP background caused
localization defects, adult worms of each genotype were randomly selected and imaged. Images
were categorized into five categories of ODR-10::GFP localization: no visible expression, ciliary
fluorescence, cell body localization with/without ciliary fluorescence, aggregation (bright
accumulation) in the neurite with/without ciliary fluorescence, and aggregation in the neurite
aggregation, cell body, and cilia expression altogether.
The strain CX3344 kyIs53 expresses ODR-10::GFP under the odr-10 promoter, and is
considered wild type (Table 1). Based on qualitative analysis, ciliary ODR-10::GFP fluorescence
is visible in only ~55% of the worms observed expressed ciliary fluorescence (Figure 8). The
ciliary fluorescence we did find was also very dim (Figure 9). No wild type animals observed
expressed any other type of localization other than ciliary fluorescence (Figure 8 & 9).
In contrast, all E3 ERAD mutants caused mislocalization in varying patterns of
expression. In hrdl-1 animals, there is a higher frequency of ODR-10::GFP expression in the
animals compared to wild type and ~94% display any visible ODR-10::GFP expression (Figure
8). hrdl-1 animals have the largest percentage of mislocalization among all E3 mutants. The
hrdl-1 mutation results in cell body fluorescence and also cytosolic aggregation patterns (Figure
10). Cell body expression with or without ciliary fluorescence in hrdl-1 animals is the most

	
  

	
  
24	
  

	
  

frequent among all E3 mutants: ~70% of the animals observed contained this expression pattern
(Figure 8).
Aggregation of ODR-10::GFP with or without ciliary fluorescence in hrd-1 was not
observed, however a combination of neurite aggregation, cell body expression and ciliary
fluorescence are observed in ~18% of the animals (Figure 8). An array of localization effects
was observed of ODR-10::GFP with the hrd-1 mutation (Figure 11). hrd-1 mutants often
frequently displayed an increase in ODR-10::GFP fluorescence in the animal: 74.3% overall
expressed ODR-10::GFP, about ~20% more often than wild type animals (Figure 8).
Interestingly hrd-1 animals had increased cell body fluorescence and cytosolic aggregation
within the neurites of the AWA neurons, which is not present in wild type ODR-10::GFP worms.
Expression of ODR-10::GFP in cilia was the most frequently observed localization pattern with
51% of the hrd-1 animals observed expressing only ciliary fluorescence. Cell body fluorescence
with or without ciliary fluorescence was observed in 14.3% of the animals (Figure 8). The
cytosolic aggregation in the neurite is only observed at the anterior end of the neurite, just
posterior to the cilia. In hrd-1 animals 5.7% expressed aggregation in the neurite with or without
ciliary fluorescence and another 2.8% expressed a combination of aggregation in the neurite, cell
body fluorescence, and ciliary fluorescence (Figure 8).
ODR-10::GFP animals with the marc-6 mutation show similar mislocalization effects as
the hrdl-1 and hrd-1 mutants (Figure 12). ODR-10::GFP fluorescence was increased compared
to wild type, with similar frequency compared to both hrdl-1 and hrd-1 mutants. ~84% of marc6 animals displayed fluorescence expression (Figure 8). Interestingly, cytosolic aggregation in
the neurite with or without ciliary fluorescence was observed at a much higher frequency in
marc-6 than hrdl-1 and hrd-1 where ~32% display this expression pattern (Figure 8). In addition,
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~16% of marc-6 animals displayed aggregation in the neurite, cell body expression, and ciliary
fluorescence (Figure 8).
The most effects on ODR-10::GFP differed between hrdl-1, hrd-1, and marc-6. Overall,
cell body expression with or without ciliary fluorescence is the most frequent with the hrdl-1
mutation, which also displayed the highest frequency of overall visible ODR-10::GFP
fluorescence (Figure 8). The greatest increase in visible cilia fluorescence alone occurs in the
hrd-1 mutation. Both HRD-1 and HRDL-1 are homologs of the Hrd1 E3 ligase in yeast
(Sasagawa et al., 2007). The similar mislocalization effects on ODR-10::GFP may be due to both
targeting the same or similar substrates in the ER lumen. Lastly, cytosolic aggregation at the
anterior end of the neurite near the cilia is most frequent phenotype found in the marc-6 mutants.
Overall, all three E3 ligase mutants displayed varying levels of fluorescence as well, in addition
to higher frequencies of visible ODR-10::GFP fluorescence in comparison to wild type. The
observed mislocalization effects of ODR-10::GFP indicate ERAD regulates ODR-10, either
directly or indirectly.

Mutations in the E2 proteins result in mislocalization of ODR-10::GFP

All E3 ligase mutations individually confer changes on localization and the frequency of
ODR-10::GFP fluorescence. Since all E3 ligase mutations affect ODR-10::GFP localization, it is
likely that ODR-10::GFP is regulated by ubiquitination within ERAD. Our next step was to
determine one or both of the E2 ubiquitin carrying ligases, UBC-6 and UBC-7, regulate ODR10. The E2 proteins interact with the E3 ligases to synthesize polyubiquitin chains on the target
substrate. Based on our results with the E3 mutants, we suspect all E3 ligase proteins are able to
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target ODR-10::GFP. Therefore, it is likely that both UBC-6 and UBC-7 are involved in
regulating ODR-10::GFP, regardless of whether they work separately or together.
The UBC-6 mutant allele (gk146975) contains a point mutation at amino acid residue
158, which resides within the helical bundle within the C-terminus of the UBC-6 protein (Figure
2). This helical bundle is thought to be responsible for interaction with the E3 ligases (Pruneda et
al., 2012). The mutation results in a nonconservative missense mutation from threonine to
isoleucine, which potentially causes disruption of the helical bundle due to the change in polarity
on the side chain; it is therefore is a putative loss of function mutation. The UBC-7 mutant allele
(gk857464) contains a point mutation resulting in a nonconservative missense mutation at P79L
(Figure 2). This mutation is only 8 amino acids away from the evolutionarily conserved catalytic
cysteine, which is responsible for interaction with the activated ubiquitin proteins (Papaevgeniou
and Chondrogianni, 2014). Although proline and leucine are both nonpolar, they are structurally
different enough to cause a disruption in the catalytic pocket of UBC-7, and in turn change the
interaction interface with the catalytic cysteine nearby. Overall, both E2 alleles are likely loss of
function mutations, and will affect ODR-10::GFP localization if they play a role in misfolded
ODR-10 degradation. In order to determine this we imaged E2 mutants in the same manner as E3
mutants in the ODR-10::GFP background.
Both E2 mutations cause ODR-10::GFP mislocalization. Our image analysis of ubc-6 in
the ODR-10::GFP background displays a variety of mislocalization and qualitative observation
of an increase in ODR-10::GFP fluorescence intensity (Figure 13). We observe an increase in
overall ODR-10::GFP expression compared to wild type. ~75% of ubc-6 animals imaged had
visible ODR-10::GFP expression (Figure 8). We also observed cell body fluorescence with or
without ciliary fluorescence in ~17% of the ubc-6 animals. ~14% of ubc-6 animals had a high
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percentage displaying aggregation in the neurite with or without ciliary fluorescence (Figure 8).
In addition, ~26% of ubc-6 worms displayed aggregation in the neurite with cell body and ciliary
fluorescence (Figure 8). Strikingly, 100% of the ubc-7 animals had visible ODR-10::GFP
expression (Figure 8 & 14). This is the largest increase in visible fluorescence expression
compared to wild type animals – an ~80% increase overall. Qualitative observations also indicate
an increased ODR-10::GFP fluorescence intensity at the cilia (Figure 14). All ubc-7 animals
displayed cell body fluorescence and ~57% of the animals displayed aggregation in the neurite
and ciliary fluorescence, in addition to the cell body expression (Figure 8).
Overall, both of the E2 mutations caused mislocalization of ODR-10::GFP. ubc-7 mutant
animals display the most extensive change in ODR-10::GFP expression compared to wild type in
which all had expression and all worms contained cell body fluorescence (Figure 8 & 14). In
addition to the E3 ligase mutants, all ERAD mutations have an effect on localization patterns of
ODR-10::GFP. However, all ERAD mutants displayed varying effects, and no two mutant
background were precisely alike. Our data shows that hrdl-1 and ubc-7 mutant animals have the
greatest effect on ODR-10::GFP localization and overall increase in expression (Figure 8).

Mutations in ERAD quantitatively increase ODR-10::GFP present in the cilia

We observed changes in ODR-10::GFP localization in all E3 and E2 mutant animals in
comparison to wild type. We also observed an increase in ODR-10::GFP fluorescence intensity
at the cilia of the ERAD mutant animals. In order to determine if ODR-10::GFP abundance is
significantly different between the mutant strains and wild type, we quantitatively analyzed
fluorescence intensities with ImageJ. The cilia in the nose were identified based on their
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fluorescence, and were traced so that overall fluorescence in the cilia could be quantified (n=20
per strain). To determine if ciliary fluorescence intensity is significantly different in comparison
to wild type we used the Tukey’s HSD statistical analysis. In our qualitative analysis, increased
ODR-10::GFP fluorescent intensity at the cilia are more consistent in the hrdl-1 and ubc-7
mutants than the hrd-1, marc-6, and ubc-6 animals. Therefore, we expected higher fluorescence
levels in all mutants, but more so in hrdl-1 and ubc-7.
The wild type ODR-10::GFP fluorescence at the cilia is dim (Figure 15). In contrast
fluorescence intensity is significantly higher in two ERAD mutants. In hrdl-1 animals, ODR10::GFP ciliary fluorescence intensity is significantly higher than wild type (p < 0.05) (Figure
15). ubc-7 animals are even brighter and have significantly higher intensity compared to wild
type (p < 0.005) (Figure 15). The ubc-7 animals have the highest level of ODR-10::GFP
expression in the cilia among all ERAD mutants. hrd-1, marc-6, and ubc-6 animals did not have
significantly different ciliary ODR-10::GFP expression compared to wild type (p > 0.05) (Figure
15). The marc-6 animals varied more in ODR-10::GFP expression in cilia. The large degree of
variation of ciliary fluorescence observed is likely due to a low number of animals containing
very bright aggregates of ODR-10::GFP in the cilia. These animals had their fluorescence
concentrated in a short distance. The hrd-1 and ubc-6 animals had a fluorescence intensity range
closer to that of wild type and were not significantly different compared to wild type (Figure 15).
Interestingly, the E2 and E3 mutations with the greatest fluorescence intensity also have a
greater effect on mislocalization of ODR-10::GFP. This may indicate a possible pathway in
which HRDL-1 and UBC-7 regulate ODR-10, either directly or indirectly. The hrd-1, marc-6,
and ubc-6 animals have no significant difference in fluorescence intensity and also show more
intermediate ODR-10::GFP mislocalization. Ciliary fluorescence quantified is a readout for the
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abundance of ODR-10::GFP localized at the cilia. Our data shows a positive relationship
between the degree of mislocalization of ODR-10::GFP and ciliary fluorescence intensity. These
results indicate the greater number of animals mislocalizing ODR-10::GFP correlates with
greater abundance of ODR-10::GFP in the cilia.

Chemoattraction is impaired with the loss of ERAD ubiquitin proteins

The increased fluorescence and mislocalization of ODR-10::GFP in our E2 and E3
mutant animals might confer a change in behavioral phenotypes such as chemoattraction to
diacetyl, the ligand of ODR-10. This could be due to misfolded or damaged ODR-10::GFP being
improperly trafficked from the ER to the cilia. We expect to see impairment in chemotaxis if this
is the case. Another possibility would be an increase in functional ODR-10::GFP localizing in
the cilia due to increased transcriptional and translational activity. An increase in functional
ODR-10 could also overwhelm the neuron and have underlying effects on chemotaxis beyond a
normal worm. In order to assess the consequences of increased ODR-10::GFP abundance at the
cilia, we measured the efficiency of chemoattraction in wild-type animals, and those harboring
mutations in ERAD genes. Chemoattraction assays were performed for all mutants with diacetyl
on one side of a 100mm plate and ethanol, which C. elegans is not attracted to, on the other side.
Animals that made it to either region remain there due to paralysis caused by azide. Assays were
quantified based on a chemotaxis index with a range of -1 (all animals at ethanol) to +1 (all
animals at diacetyl). To determine if there was statistical significance between wild type animals
and ERAD mutants, we determined p values by Tukey’s HSD analysis.
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Wild type (N2) animals have a high chemotaxis index, with ~80% of animals moving to
the diacetyl (Figure 16). Animals containing a non-functional allele of the odr-10 gene were used
in order to determine what a chemotaxis index should be if ODR-10 was completely absent (the
negative control) (Ryan et al., 2014). odr-10 animals have a chemotaxis index close to 0
indicating no preference to move towards diacetyl or ethanol (Figure 16). In contrast the ERAD
mutants all have chemotaxis indices between wild type and odr-10, and all are significantly
different compared to wild type and odr-10 (p < 0.05). hrd-1 animals have the highest
chemotaxis index compared to all the ERAD mutants (Figure 16). The marc-6 and ubc-6 animals
have chemotaxis indices just below hrd-1 animals (Figure 16). hrd-1, marc-6, and ubc-6 animals
all have intermediate chemotaxis impairment compared both to wild type and odr-10. The
intermediate chemotaxis impairment suggests a trend that reflects the more intermediate effects
that these ERAD mutants confer on localization and abundance of ODR-10::GFP. In contrast,
hrdl-1 and ubc-7 animals have the lowest chemotaxis indices suggesting a greater impairment in
chemoattraction similar to odr-10 knock out animals. Our results suggest a relationship of higher
chemotaxis impairment with greater mislocalization of ODR-10::GFP (Figure 16).
The E2 mutant animals also show similar chemotaxis impairment to the E3 ligase
mutants. The ubc-7 putative knockdown animals had a much lower chemotaxis index in
comparison to the ubc-6 animals. The ubc-7 animals have a chemotaxis index similar to that of
hrdl-1 and odr-10 animals, and had the lowest chemotaxis index of all the ERAD mutants
(Figure 16). The ubc-6 animals have a chemotaxis index that was more intermediate, similar to
hrd-1 and marc-6 animals (Figure 16). Through Tukey’s HSD analysis, both E2 mutants have
significantly lower chemotaxis indices than wild type animals (p < 0.005) and are also
significantly higher than odr-10 knock out animals.
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Altogether, our data shows a relationship in which the animals with mutations that confer
greater ciliary fluorescence intensities also display the most impaired chemotaxis. hrdl-1 and
ubc-7 animals have the greatest effect on overall presence of ODR-10::GFP fluorescence,
mislocalization of ODR-10::GFP, highest ciliary fluorescence intensities, and the lowest
chemotaxis indices of the ERAD mutants. Hrd-1, marc-6, and ubc-6 do display effects on ODR10::GFP localization and chemotaxis, however all three have a more intermediate trend and are
less severe than hrdl-1 and ubc-7 animals.

E2 ubiquitin proteins localize at the ER in C. elegans

We predict that the E2 ubiquitin proteins are universally involved in ERAD in all cells
within C. elegans, however this has yet to be shown. Based on the mechanism that the E2
proteins either work together or individually with different E3 ligase proteins this is likely true.
The localization of the E2 proteins is also not known in C. elegans. It is likely that both proteins
localize to the ER, the site of ERAD. This is supported by the fact that both E2 proteins contain
ER membrane association domains (Boban et al., 2014; Deng and Hochstrasser, 2006). Based on
the localization defects of ODR-10::GFP and chemotaxis impairment in the absence of wild type
ubc-6 and ubc-7, it is likely both E2 proteins are present in the AWA neuron. We wanted to
determine the localization of the E2 proteins and designed transgenic animals that include coding
sequences of both E2 proteins downstream of the odr-10 promoter and GFP attached on the Cterminus. The odr-10 promoter is only active in the AWA neuron; therefore our E2 proteins with
GFP should only be expressed in the AWA neurons. We observed UBC-6::GFP and UBC7::GFP fluorescence in the cell bodies of the AWA neurons. Expression was only observed at the
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cell body and we also observed expression in various stages of development. The site of ERAD,
the ER, is also in the cell body (Unpublished Data, Sam Witus & Ailion Lab), which suggests
that the E2 proteins are likely at the ER.
Interestingly, E2::GFP expression driven by the odr-10 promoter was not observed in
well-fed and/or uncrowded transgenic carriers. Gravid adult worms on overcrowded and starved
plates were the only animals we could observe fluorescence expression, but only in about 1 in 30
worms (Data not shown). We also observed a similar increase in odr-10 promoter activity in
CX3344 (kyIs53) animals that were starved and overcrowded where ODR-10::GFP at the cilia
was visibly brighter and cell body expression was present (Unpublished Data, Ellen Zocher).
Plates are overcrowded when the number of worms on the plate exceeds the available nutrient
availability and available space. Starved animals had diminished all food sources on the plate
they are contained and therefore had no food available for at least 24 hours prior to imaging.
When E2::GFP fluorescence was observed it was always at the cell body in the AWA neuron
(Figure 17 & 18). This also supports the effects we observe our E2 mutants have on ODR-10.
We can now visualize that the E2 proteins localize at or near the site of ERAD (Figure 17 & 18).
Our mutations and their corresponding effects are most likely due to UBC-6 and UBC-7 playing
a role in ERAD, and potentially as direct regulators of ODR-10.
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DISCUSSION

The odorant receptor ODR-10 in C. elegans has not been studied before regarding its
regulation by ERAD. Thus ODR-10 is a novel tool for studying this regulatory mechanism. The
mutations of the ERAD-associated E3 and E2 proteins all have an effect on ODR-10 localization
and chemotaxis, however some more than others. Our findings suggest that damaged or
misfolded ODR-10 protein is normally degraded by an ERAD mechanism, and that there is
specificity among the E3 ligases and cooperation between the E2 proteins for proper ODR-10
maintenance.

Results of mutations of E3 ligases

Our findings suggest that all E3 ligases can target ODR-10, however some E3 ligases
potentially have a higher propensity than others to target ODR-10. Based on mislocalization
patterns and fluorescence quantification, the hrd-1 and marc-6 mutations had a less severe effect
than the hrdl-1 mutation. Therefore, if ODR-10 is a direct target, it is most likely that HRDL-1 is
the primary E3 ligase to target the ODR-10 substrate, although HRD-1 and MARC-6 can also
target ODR-10 with less affinity. The hrdl-1 mutants also more often have cell body
fluorescence and have significantly increased ciliary fluorescence of ODR-10::GFP. The marc-6
and hrd-1 animals had lower fluorescent levels that were not significantly different than our wild
type strain, CX3344 (kyis53). Our imaging data is supported by our chemotaxis assays in which
hrdl-1 animals were the most impaired with hrd-1 and marc-6 animals at a more intermediate
chemotaxis index between wild type and odr-10 knockout animals, (discussed in depth below).
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Overall, when HRDL-1 is missing there is a larger effect on ODR-10 regulation and cellular
upkeep, which suggests this E3 ligase has the greatest affinity to target ODR-10.
Without biochemically showing a direct relationship between ODR-10 and the E3 ligases
we are unable to tell if HRDL-1 is specifically and directly targeting ODR-10 or if there is an
intermediate interaction at play. One possible mechanism that could cause the phenotypes we
observed is that HRDL-1 may target a different protein, which in turn affects ODR-10 regulation
and chemotaxis function. There are proteins that assist in trafficking of GPCR proteins, such as
ODR-10, at the ER and also at the plasma membrane (Magalhaes et al., 2012). If these proteins
were to be misregulated due to the ERAD mutations we may observe similar results of ODR-10
misregulation. We also do not know if what we are observing is cell autonomous as the E3
mutations are not specific for the AWA neurons and are present in every cell in the animal. For
example, the AWA neuron forms gap junctions with the AIA interneuron (Larsch et al., 2015). If
the ERAD mutations cause protein misregulation in the AIA interneuron, signaling to the AWA
neuron may change and then impact AWA cell activity. Therefore, the phenotypes could be due
to signaling from other cells in response to the E3 mutations.

Results of mutations of E2 proteins

Based on our findings with the E2 mutant animals, both UBC-6 and UBC-7 play roles in
regulating ODR-10. Mutation of either E2 protein resulted in changed in ODR-10 localization
patterns, abundance, and chemotaxis impairment. The ubc-6 mutant had a lower fluorescence
intensity overall in comparison to the ubc-7 mutant animals. Once again this may not be a direct
relationship with ODR-10, but our observations that HRDL-1 may also be the primary E3 ligase
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to target ODR-10 could suggest a potential mechanism of which E2 and E3 proteins are involved
in misfolded ODR-10 regulation. Previous studies suggested HRDL-1 specifically interacted
with UBC-6 in order to ubiquitinate substrate targets (Hirsch et al., 2009). However, a recent
yeast study presents a mechanism in which both UBC-6 and UBC-7 work in tandem with their
cognate E3 ligase in order to polyubiquitinate the target (Weber et al., 2016). In our animals, if
HRDL-1 interacts with UBC-6, and not UBC-7, we would expect to see a more severe effect in
ubc-6 mutant animals than ubc-7. However, in our findings we observed a higher mislocalization
effect, fluorescence intensity, and impaired chemotaxis in the ubc-7 mutant in comparison to
ubc-6. We also observe less severe effects in hrd-1 and marc-6 mutant animals and both E3
ligases are known to interact specifically with UBC-7 (Cohen et al., 2015). If HRD-1 and
MARC-6 were to be the only E3 ligases to interact with UBC-7, we would expect to see similar
levels of misregulation of ODR-10. However, in our study we only see intermediate effects with
these E3 ligase mutants. Therefore it is unlikely that the E3 ligases interact specifically with only
one E2 protein and that the E2 proteins work through entirely separate pathways.
Based on our findings, the effects we observed suggest the E2 proteins could work in
tandem in order to effectively polyubiquitinate target substrates (Figure 19). The ubc-6 mutant
may have a lesser effect on misregulation of ODR-10 because if UBC-6 is absent, UBC-7 can
prime and polyubiquitinate the target as well (Weber et al., 2016). Therefore, the ubc-6 mutant
animals show some effect, though UBC-7 may be able to compensate the role of UBC-6 in this
context. If UBC-7 is no longer functional, however, UBC-6 is able to prime the substrate target
but unable to polyubiquitinate, therefore less misfolded ODR-10 is likely degraded in ubc-7
mutant animals (Weber et al., 2016). If this mechanism were to play a role in regulation of ODR-
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10 there would be more misregulation in the absence of UBC-7. Our observations of larger
effects in the ubc-7 mutant animals support this potential mechanism.

Impaired chemotaxis

Because of the varying ODR-10::GFP localization and an increase in fluorescence
presence and intensity in the ERAD E2 and E3 mutants, we expected a change in the behavioral
phenotype of chemoattraction. The mislocalization and increased fluorescence of ODR-10::GFP
suggests there is more of the protein present in the mutant animals. However, it is unknown if the
ODR-10::GFP proteins present in these mutants is functional or misfolded. It has been shown
ERAD substrates that are misfolded are able to exit the ER if they still present the correct protein
structural fold for an exit signal (Kincaid and Cooper, 2007). Therefore, it is possible misfolded
ODR-10 is exported to the Golgi from the ER if this exit signal is still present in their structure.
This would also explain why we observe cell body fluorescence; these misfolded proteins may
not present the correct exit signal in their folded structure to be exported from the ER and cause
protein aggregation.
The mislocalization effects we see may be due to too much functional ODR-10 protein
present and that not all of the protein can localize to the cilia. Increasing transcriptional activity
for certain proteins has been shown under stress responses such as starvation and even in
nonfunctional ERAD models (Larance et al., 2015; Sakaki and Kaufman, 2013). Improper or
reduced ERAD ubiquitination may cause cellular stress, possibly due to other protein aggregates
we have not observed in our model. These could initiate similar stress responses under ER
quality control. Production of ODR-10 protein may be increased as well in response to the
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absence of one of the E2 or E3 proteins involved in ERAD. This may be a stress response that
increases transcription and translation of ODR-10, therefore completely functional ODR-10 is
being processed and localizing to the cilia.
The increase in ODR-10 at the cilia, whether it is damaged or functional, could cause a
behavioral phenotype change. If misfolded ODR-10 is localizing at the cilia, then we would
expect this ODR-10 would not function and could cause impaired chemoattraction to diacetyl. If
the ODR-10 is still functional but is increasing at the cilia, the overproduction of ODR-10 could
be overwhelming the chemosensory neuron and we may still observe chemoattraction
impairment. When exposed to diacetyl over a prolonged period of time the animals become
desensitized (Larsch et al., 2015). The increased ODR-10 expression observed in ERAD mutants
could be overstimulating the AWA neuron and desensitizing the animal faster than normal. This
is a possibility if it is functional ODR-10 we observe in greater abundance at the cilia.
Regardless of the mechanism, we observe significant impairment in all E2 and E3 mutant
animals in comparison to wild type animals. We also observe varying degrees of impairment
between E3 ligase and E2 mutants. The hrdl-1 mutant animals have the lowest chemotaxis index
among the E3 ligase mutants, and these animals’ chemotaxis indices were closer to the odr-10
knockout mutant animals, though still significantly different. The marc-6 and hrd-1 mutant
animals have a more intermediate chemotaxis index but are both still significantly less than wild
type animals. Based on observations among the hrd-1 animals, the chemotaxis assays portrayed
the worms going in the direction of diacetyl, just taking much longer than the 2-hour timespan to
make it to the diacetyl point. The hrd-1 worms seemed to collect and remain at the starting point
of the assay (i.e. in the middle of the assay plate) for a much longer period before moving
towards diacetyl, and not many animals went in the direction of ethanol. If left for a longer
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period, it is likely these animals could show similar chemotaxis indices to that of wild type. The
hrdl-1 animals were more spread out on the plates and we did not observe this trend to go solely
towards the diacetyl.
The E2 mutant animals also had varying impaired chemotaxis indices and both were
significantly impaired in comparison to wild type animals. The ubc-7 mutants had a lower
chemotaxis index similar to that of the hrdl-1 animals. The ubc-6 mutants had a higher
chemotaxis index similar to the hrd-1 and marc-6 mutant strains. Interestingly, the ubc-6 animals
were observed to have a similar trend to be going to the direction of diacetyl similar to that of the
hrd-1 animals after 2 hours. The ubc-7 mutants, however, were more spread out across the plate
and did not show this trend. Instead, they behaved similarly to the hrdl-1 and marc-6 animals.
Overall, the hrdl-1 and ubc-7 mutant animals had the lowest chemotaxis index further supporting
the proposed mechanism of HRDL-1 specificity and E2 cooperation.

E2::GFP localization

Our transgenic strains for observing E2 localization enabled us to visualize the proteins
localized within the cell bodies of the AWA neurons. We suspect the E2 proteins are localized at
the ER membrane, the site of ERAD. Future studies should fluorescently mark the ER in these
neurons and determine if the E2::GFP fluorescence we observed within the cell bodies colocalizes with the ER. We also observed nuclear localization suggesting a possible nuclear role
for those E2 proteins. The expression pattern and/or cell specific expression of the E2 genes still
not known, and is uncharacterized for the AWA neurons. A future study will allow us to
determine the promoter activity of the E2 genes in C. elegans. We have designed primers and
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have successfully amplified the E2 promoters, which can now be used to create plasmids with
the E2 promoter region upstream of GFP. The importance of ERAD in regulating protein
production and the highly involved roles both E2 proteins play suggests the E2 promoters are
most likely active in every cell and therefore we expect to see promoter activity in the AWA
neurons. Novel promoter reporter strains will help to demonstrate this.
E2::GFP expression was not observed very often in the Podr-10::ubc-X::GFP transgenic
animals. We also only observed E2::GFP expression in starved and overcrowded animals. In
well fed, uncrowded wild type (kyIs53) animals, we do observe increased fluorescence of ODR10::GFP when worms undergo stressful conditions like starvation and overcrowding
(Unpublished Data, Ellen Zocher). kyIs53 contains ODR-10::GFP driven by the odr-10
promoter, and our transgenic strains contain E2::GFP driven by the same promoter. In the
Podr.10::ubc-X::GFP transgenic animals under well fed, uncrowded conditions, we did not
observe E2::GFP expression. This is likely due to their expression being driven by the weak/low
activity odr-10 promoter. It is possible that the increase in expression of E2::GFP is due to the
odr-10 promoter being more active under starved and overcrowded conditions.
Another possibility could be that only a small amount of UBC-6 and UBC-7 is expressed
and maintained in the cell. The UBC-6 and UBC-7 orthologs in yeast have a high turn over rate
to maintain specific levels, and could also be true in C. elegans (Kreft and Hochstrasser, 2011;
Ravid and Hochstrasser, 2007). A high turnover rate may also explain why we did not observe
E2::GFP expression in normal animals as these proteins are possibly maintained at very low
levels of expression.
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Conclusion

In our study, we point to possible mechanisms of ERAD within C. elegans that could
regulate the ODR-10 receptor, and therefore neural receptor proteins in general. Our findings
suggest a mechanism where three E3 ligases (HRD-1, HRDL-1, and MARC-6) have some
specificity for a target substrate (ODR-10::GFP), and some E3 ligases are redundant or substitute
for other E3 ligases under mutant conditions. Our findings also suggest the E2 proteins, UBC-6
and UBC-7, both play roles in regulating ODR-10::GFP, and may work in tandem to degrade the
misfolded protein. Indeed a recent study in yeast shows both E2 proteins work together to
polyubiquitinate substrates (Weber et al., 2016). In the absence of individual ERAD functional
proteins we also observe a behavioral change in the animals, which may present a case as to why
certain neurological symptoms may appear in degenerative diseases.
Our data suggests a relationship between the level of impaired chemotaxis impairment
and the level of ODR-10::GFP abundance at the AWA cilia. We observe these with all the
ERAD mutants, with the highest extremes in the absence of HRDL-1 or UBC-7. Overall, we
propose HRDL-1 is the main E3 ligase to target ODR-10 based on the relationship this E3
mutation causes the most chemotaxis impairment and highest fluorescence increase. The loss of
MARC-6 or HRD-1 only shows intermediate effects, which suggests they play a lesser role in
regulating ODR-10. The E2 proteins may work in tandem to polyubiquitinate ODR-10 once it is
recognized by HRDL-1.
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Broader Significance

Previous studies have shown that HRD-1 and MARC-6 are necessary for C. elegans
development in the presence of long term ER stress, however HRDL-1 is not (Sasagawa et al.,
2007). Here, we observe HRDL-1 is necessary for proper ODR-10 upkeep in adult animals,
whereas HRD-1 and MARC-6 have a more intermediate effect. Therefore our study points to a
possible role of HRDL-1 post development related to cellular upkeep in neurons that does not
require HRD-1 and MARC-6.
Our study suggests that if mutations in ERAD were to exist in an organism, receptors
targeted by the E2 or E3 protein could accumulation and potential aggregation at the ER in
neurons. It is also possible misfolded receptors may accumulate and potentially aggregate at the
ER in neurons. It is also possible misfolded receptors may accumulate at the synapse membrane
and result in impairment of the phenotype the receptor is responsible for. This could be the case
in humans, as there are well-conserved homologs of all three E3 ligases in C. elegans. The
human homologs of HRD-1, HRDL-1, and MARC-6 are Hrd1, gp78, and MARCH6 respectively
(Sasagawa et al., 2007). There are 6 known ERAD E3 ligases in humans, which may indicate
there are more interactions and specific roles the E3 ligases may take part in in comparison to
yeast and C. elegans (Tamura et al., 2010). Three identified E2 proteins involved in ERAD in
humans, are also orthologs to the C. elegans E2 proteins: UBE2J1 and UBE2J2 are orthologs of
UBC-6, and UBE2G2 is the ortholog of UBC-7 (Burr et al., 2011). The E2 and E3 ligase
homologs interact in a similar fashion as C. elegans, which could suggest similar roles are
played. The human Hrd1 protein interacts with UBE2J1 and gp78 interacts with UBE2G2 (Burr
et al., 2011; Christianson et al., 2011). The gp78 protein also works downstream of Hrd1 in
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marking substrates for degradation (Zhang et al., 2015). It is unknown which E2 proteins the
mammalian MARCH6 interacts with.
Mammalian E2:E3 interactions require further study. However early investigations show
some insight as to how conserved functions are across species. Interestingly, gp78 and UBE2G2
interact and our study points to HRDL-1 and UBC-7 interaction and possibly also UBC-7 and
UBC-6 working in tandem. Their roles may be conserved and it would also be interesting to
study if the mammalian UBE2G2 works in tandem with UBE2J1 or UBE2J2. This may be
possible due to gp78’s acting downstream of Hrd1 to polyubiquitinate substrates. Since gp78
interacts with UBE2G2 and Hrd1 interacts with UBE2J1, this polyubiquitination could be due to
the E2 proteins working in tandem but still interacting with their respective E3 ligases. Overall,
our study indicates a possibility to conserved interactions between E2 and E3 ligases involved in
ERAD.
In humans, ERAD mutations may result in the loss of olfaction and possibly other
impaired senses early on in neurodegenerative patients if neuronal upkeep has similar
maintenance regarding HRDL-1. Identifying probable causes of mutations in ERAD
ubiquitination proteins in human neurodegenerative patients could lead to a better understanding
of what may be creating early symptoms. It is possible we could also develop treatments to
prevent or prolong the time to onset of these symptoms if we can repair or enhance ERAD in
these patients. For example, a recent study showed prolonged ER stress increased reactive
oxygen species which play a significant role in neurodegenerative diseases (Zeeshan et al.,
2016). In another case, Hrd1 is shown to promote the degradation of the amyloid precursor
protein (APP), which is responsible for the accumulation of amyloid β protein in Alzheimer’s
patients. When Hrd1 is no longer present, as observed in Alzheimer’s patients, there is an
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increase in APP (Kaneko et al., 2012). This further suggests ERAD proteins play a role in cell
maintenance and if no longer present can induce the onset of neurodegenerative symptoms.

Future Directions

To further support and clarify our findings the Dahlberg lab plans to further explore the
role of the E3 ligase and E2 proteins in response to regulation of ODR-10 and also the glutamate
receptor GLR-1. GLR-1 will be studied to determine if we observe a similar effect in
misregulation on a different receptor expressed in different neurons. The Dahlberg lab also plans
to biochemically analyze the increase in ODR-10::GFP abundance and also ubiquitin
modification levels of ODR-10 in all ERAD mutant animals. We plan to determine if this
increase in ODR-10 can be biochemically quantified and also determine if there is an increase in
misfolded or normal receptor. These plans will further our understanding as to what may be
causing the mislocalization, fluorescence increase, and chemotaxis impairment we observed of
ODR-10 in ERAD mutant animals.
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Strain &
allele name
Bristol N2

Mutation or transgene

Description

Strain source

Wild type

Dahlberg Lab

sel-11 tm1743

473bp deletion, 38bp
insertion

VC35 gk28

1981bp deletion

VC20284
gk121407

W391stop

VC20545
gk146975

T158I

VC40870
gk857464

P79L

CX32 ky32

odr-10 null allele

Wild type animals, used to
produce all other strains
hrd-1 putative null allele,
large deletion, FJ861 is the
backcrossed strain used
hrdl-1 putative null allele,
large deletion, FJ863 is the
backcrossed strain used
marc-6 putative null allele,
premature stop, CLD33 is
backcrossed strain used
ubc-6 putative loss of
function allele,
nonconservative missense,
CLD41 is backcrossed
strain used
ubc-7 putative loss of
function allele,
nonconservative missense,
CLD43 is backcrossed
strain used
results in loss of attraction
of diacetyl
Wild type ODR-10::GFP

CX3344 kyIs53 Podr-10::ODR-10::GFP
CLD32

kyIs53; tm1743

CLD31

kyIs53; gk28

CLD38

kyIs53; gk121407

CLD35

kyIs53; gk146975

CLD42

kyIs53; gk857464

CLD39

Podr-10::UBC-6::GFP

CLD40

Podr-10::UBC-7::GFP

hrd-1 in Podr-10::ODR10::GFP background
hrdl-1 in Podr-10::ODR10::GFP background
marc-6 in Podr-10::ODR10::GFP background
ubc-6 in Podr-10::ODR10::GFP background
ubc-7 in Podr-10::ODR10::GFP background
Transgenic strain used for
UBC-6::GFP localization
Transgenic strain used for
UBC-7::GFP localization

Caenorhabditis
Genetics Center
Caenorhabditis
Genetics Center
Million
mutation project
Million
mutation project

Million
mutation project

Caenorhabditis
Genetics Center
Caenorhabditis
Genetics Center
Dahlberg Lab
Dahlberg Lab
Dahlberg Lab
Dahlberg Lab
Dahlberg Lab
Dahlberg Lab
Dahlberg Lab

Table 1. List of C. elegans strains used in our study. Strain and allele name provided with
mutation/transgene, description of purpose in our study, and from where the strain was sourced.
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Mutation
detected
hrd-1
hrdl-1

marc-6

ubc-6

ubc-7

PCR
step
#1

Primer Name

tm1743 FWD
tm1743 REV
WT
hrdl-1 FWD
screen hrdl-1 REV
Mutant hrdl-1 FWD
screen gk28 REV
#1
marc-6 exon FWD
marc-6 exon REV
#2
marc-6 gk121407 FWD
marc-6 gk121407 REV
#1
UBC-6 MMP FWD
UBC-6 MMP REV
UBC-6 int MMP FWD
#1
UBC-7 MMP FWD
UBC-7 MMP REV

Primer sequence
5’ GGTATCAGCTGGACTAATGATTGG 3’
5’ GAACGGACGAACTGAGAAGAGTG 3’
5’ GAGCCATCTGTAGAATATGGACAC 3’
5’ GTGTGCCCGGACAATGCTTC 3’
5’ GAGCCATCTGTAGAATATGGACAC 3’
5’ CGGGGAGCCGTTTGTGTCAATCC 3’
5’ CGTGAAGAAGGTGAAGC 3’
5’ CGATGACACTTAGGAACC 3’
5’ CTCCGCCCATTTTTCCGTGCCGC 3’
5’ CCAGACAATTTTCGTTACATGTGCG 3’
5’ GCAATACGCCCATTTCTGC 3’
5’ CGTCCTGATGATGTTTCC 3’
5’ CGTTGATTGGATTCCTGCC 3’
5’ GCTACTGGCACCTTCGTC 3’
5’ CGAGTCCAACGCTTATGAGG 3’

Table 2. Primers used for detecting mutations in the E2 genes, ubc-6 and ubc-7, and E3 genes,
hrd-1, hrdl-1, and marc-6 when crossing mutations into the ODR-10::GFP background. *marc-6
genotyping requires sequential PCR amplification followed by restriction digestion by Ear1.
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Promoter Primer
Region: Name:
ubc-6

ubc-7

Primer designed:

Restriction
Enzyme:

	
  	
  
(5’)	
  CCGGAAGCTTGCTGACTCTTCGATGG	
  (3’)	
  
	
  

HindIII

ubc6lpror
(3’ rev)

(5’)	
  CCGGGGATCCTTTATTCTCTAAATTCTCGTAC	
  (3’)

BamHI

ubc7prof
(5’ fwd)

(5’)	
  GATAAAGCTTTGGCAAGGTAAGAGC	
  (3’)	
  

HindIII

ubc7pror
(3’ rev)

(5’)	
  CCGGGGATCCCTATCTAGAAATAAATATAGAATTATCG	
  (3’)

BamHI

ubc6lprof
(5’ fwd)

Table 3. Primers designed for amplifying the promoter regions of ubc-6 and ubc-7 oriented from
5’ end to 3’ end. Green highlighted regions indicate restriction enzyme site engineered into the
primer for inserting the amplicon into an expression vector.
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Coding
Sequence:
ubc-6

ubc-7
(GFP
downstream)

ubc-7
(GFP
upstream)

Primer
Name:
ubc6cs1f
(5’ fwd)

Primer
designed:
	
  	
  
(5’)	
  CCGGGGTACCAAAAAATGAGTGAGCAGTAC	
  (3’)	
  
	
  

Restriction
Enzyme:
KpnI

ubc6cs1r
(3’ rev)

(5’)	
  GGCCGGTACCAACTCGGAACCG	
  (3’)

KpnI

ubc7cs1f
(5’ fwd)

(5’)	
  CCGGGGTACCAAAAAATGGAGCAATCCTC	
  (3’)	
  

KpnI

ubc7cs1r
(3’ rev)

(5’)	
  GGCCGGTACCCATTCTTCTTGAC	
  	
  (3’)

KpnI

ubc7cs2f
(5’ fwd)
ubc7cs2r
(3’ rev)

	
  
(5’)	
  CCGGGGTACCaaaaaATGGCGGCCGCgGAGCAATCCTC	
  (3’)	
  
(5’)	
  GGCCGGTACCTCATTCTTCTTGAC	
  	
  (3’)

KpnI, NotI
KpnI

Table 4. Primers used to amplify the coding sequence regions of ubc-6 and ubc-7 oriented from
5’ end to 3’ end. Green highlighted regions indicate restriction enzyme site KpnI incorporated
into primer, purple highlighted region indicates NotI enzyme restriction site. Restriction sites
were engineered to allow the amplified region to be inserted into an expression vector.
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Figure 1. Model of ER-associated degradation (ERAD) in the neuron. 1) The E3 ligase targets
and binds to the misfolded receptor protein. 2) The E2 ubiquitin carrying protein associates with
the E3 ligase-receptor complex and polyubiquitinates the misfolded receptor. 3) The
polyubiquitinated misfolded receptor is removed from the ER membrane into the cytosol. 4) The
polyubiquitinated misfolded receptor is then targeted for degradation by the 26S proteasome in
the cytosol.
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Figure 2. Schematic representations of gene structures and mutations resulting in putative lossof-function mutations in the following E2 and E3 ligase mutant strains: gk146975 (ubc-6),
gk857464 (ubc-7), gk28 (hrdl-1), tm1743 (hrd-1), and gk121407 (marc-6). Brackets indicate
deletions of gene sequences. hrd-1 contains a deletion and subsequent insertion spanning exons
1-2, hrdl-1 contains a deletion spanning exons 1-5, Arrowheads indicate where point mutations
occur with respect to exons and introns within the gene sequence of the E2 and E3 ligase genes.
ubc-6 contains a nonconservative missense mutation T158I in exon 5, ubc-7 contains a
nonconservative missense mutation P79L in exon 3, and marc-6 contains a premature stop at the
end of exon 4, subsequently removing exons 5-8. Scale bar represents 100bp. Schematics were
made using the Exon-Intron Graphic Maker found at www.wormweb.org.
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S. cerevisiae
C. elegans
H. sapiens

MA-----TKQAHKRLTKEYKLMVENPPPYILARPNEDNILEWHYIITGPADTPYKGGQYH
MSEQYNTKNAGVRRLMKEA-MELRQPTEMYHAQPMEDNLFEWHFTIRGTLGTDFEGGIYH
METRYNLKSPAVKRLMKEA-AELKDPTDHYHAQPLEDNLFEWHFTVRGPPDSDFDGGVYH
*
.. . :** **
:.:*
*:* ***::***: : * .: :.** **

55
59
59

S. cerevisiae
C. elegans
H. sapiens

GTLTFPSDYPYKPPAIRMITPNGRFKPNTRLCLSMSDYHPDTWNPGWSVSTILNGLLSFM
GRIIFPADYPMKPPNLILLTPNGRFELNKKVCLSISGYHPETWLPSWSIRTALLALIGFL
GRIVLPPEYPMKPPSIILLTANGRFEVGKKICLSISGHHPETWQPSWSIRTALLAIIGFM
* : :* :** *** : ::* ****: ..::***:*.:**:** *.**: * * .::.*:

115
119
119

S. cerevisiae
C. elegans
H. sapiens

TSDE-ATTGSITTSDHHKKTLARNSISYNTFQN--VRFKLIFPEVVQE-----------PSTPGGALGSLDYPPKERQRLAKLSCEWKCKECGCVMKTALLPITEDGQLKQT-EEAKTL
PTKGEGAIGSLDYTPEERRALAKKSQDFCCEGCGSAMKDVLLPLKSGSDSSQADQEAKEL
:
.: **:
..:: **: * .:
.
::*

160
178
179

S. cerevisiae
C. elegans
H. sapiens

------------NVETLEKRKLDEGDAANTGDETE---DPFTKAAKEKV----------AAQLKFQDESVVKKEVEAANNQKNPTETEPSEETSSVPTENVEESEE---------DADE
ARQISFKAEVNSSGKTISESDLNHSFS--LTDLQDDIPTTFQGATASTSYGLQNSSAASF
. :.
. ..
: .
: .

194
229
237

S. cerevisiae
C. elegans
H. sapiens

------ISLEEILDPEDRIRAEQALRQ-S------ENNSKKDGKEPNGSSSMVYIGIAIF
REEGTTVNVNSSEVPD--VAQPAVQPIRDPQPLVFQHHAPRLASTNFDYT-LLYK-IPVI
HQPTQPVAKNTSMSPRQRRAQQQSQRRLSTSPDVIQGHQPRDNHTDHGGSAVLIV-ILTL
: :
*
.
: : :
. : ::
* :

241
285
296

S. cerevisiae
C. elegans
H. sapiens

LFLVGLFMK--------------------ALCFAIFFT-LLARRFLVDNLTSPKDGSEL
ALAALIFRRIYLANEYIFDFEL-------:
:*

250
314
318

Figure 3. Amino acid sequence alignment of C. elegans UBC-6 in comparison to homologs S.
cerevisiae (yeast) Ubc6 and H. sapiens (human) UBE2J1. Yellow highlighted threonine indicates
missense mutation T158I in strain VC20545 gk146975 located within the C-terminus helical
bundle. The corresponding amino acid in H. sapiens is an aspartate and in S. cerevisiae is a
lysine. Alignment performed using ClustalOmega.
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C. elegans
S. cerevisiae
H. sapiens

MEQ-SSLLLKKQLADMRRVPVDGFSAGLVDDNDIYKWEVLVIGPPDTLYEGGFFKAILDF
MSKTAQKRLLKELQQLIKDSPPGIVAGPKSENNIFIWDCLIQGPPDTPYAEGVFNAKLEF
MAGTALKRLMAEYKQLTLNPPEGIVAGPMNEENFFEWEALIMGPEDTCFEFGVFPAILSF
*
:
* : ::
*: ** .::::: *: *: ** ** : *.* * *.*

59
60
60

C. elegans
S. cerevisiae
H. sapiens

PRDYPQKPPKMKFISEIWHPNIDKEGNVCISILHDPGDDKWGYERPEERWLPVHTVETIL
PKDYPLSPPKLTFTPSILHPNIYPNGEVCISILHSPGDDPNMYELAEERWSPVQSVEKIL
PLDYPLSPPKMRFTCEMFHPNIYPDGRVCISILHAPGDDPMGYESSAERWSPVQSVEKIL
* *** .***: * .: **** :*.******* ****
**
*** **::**.**

119
120
120

C. elegans
S. cerevisiae
H. sapiens

LSVISMLTDPNFESPANVDAAKMQRENYAEFKKKVAQCVRRSQEE
LSVMSMLSEPNIESGANIDACILWRDNRPEFERQVKLSILKSLGF
LSVVSMLAEPNDESGANVDASKMWRDDREQFYKIAKQIVQKSLGL
***:***::** ** **:**. : *:: :* : .
: :*

164
165
165

Figure 4. Amino acid sequence alignment of C. elegans UBC-7 in comparison to homologs S.
cerevisiae (yeast) Ubc7 and H. sapiens (human) UBE2G2. Yellow highlighted proline indicates
missense mutation P79L in strain VC40870 gk857464 and indicates this proline is conserved
across species. Green highlighted cysteine is the well-conserved catalytic cysteine in E2 proteins
responsible for binding to ubiquitin. Alignment performed using ClustalOmega.
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Primer Name:

Primer Sequence:

LD5 forward

(5’) GGACCCAAAGGTAT (3’)

LD4 reverse

(5’) GGTGGGAGCACA (3’)

Figure 5. Plasmid diagram of Podr-10::ODR-10::GFP. LD5 forward begins amplification just
before the GFP coding sequence, and LD4 ends amplification just after the GFP coding
sequence. Positive band size is 1168bp and indicates animals are carriers of ODR-10::GFP.
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Figure 6. Plasmid maps of the E2 promoter reporter constructs Pubc-6long-GFP (left) and Pubc7-GFP (right). The PSAA775 plasmid was used as the backbone for the creation of the
constructs. Restriction digest sites used to incorporate promoter regions, BamHI and HindIII, are
noted. The promoter regions are shown in orange; GFP is shown in green.
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P od r -1 0 - G F P- ub c - 7 c s 2 (P S AA 7 7 5 )

Figure 7. Plasmid maps of E2::GFP fusion reporter constructs inserted downstream of the odr-10
promoter. Podr-10-ubc-6cs1-GFP (top), Podr-10-ubc-7cs1-GFP (middle), and Podr-10-GFPubc-7cs2 (bottom). The PSAA775 plasmid if the backbone for these constructs. Restriction
digest sites KpnI and NotI used for coding sequence insertion indicated on maps. GFP is in green
and E2 coding sequences in dark blue.
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Figure 8. Quantitative data of ODR-10::GFP localization phenotypes observed in wild type
(N=27), hrd-1 (N=35), hrdl-1 (N=33), marc-6 (N=38), ubc-6 (N=35), and ubc-7 (N=28) mutants
in the ODR-10::GFP background. Gravid adult worms were imaged and categorized by no
visible fluorescence, ciliary fluorescence only, cell body fluorescence with or without ciliary
fluorescence, aggregation in the neurite with or without ciliary fluorescence, and aggregation in
the neurite with cell body and ciliary fluorescence.
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Figure 9. Representative images (n=12) of CX3344 kyIs53 wild type gravid adult animals
expressing ODR-10::GFP. Images taken on Leica DMi6000 at 400X total magnification.
Contrast and brightness both adjusted to +20% (in PowerPoint) to enable fluorescence viewing.
These are typical localization patterns observed in wild type animals where ODR-10::GFP
expression is not frequent and if observed it is very dim.
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Figure 10. Representative images (n=12) of hrd-1 mutant gravid adult animals in the ODR10::GFP background. Images taken on Leica DMi6000 at 400X total magnification. Contrast and
brightness are both adjusted to +20% (in PowerPoint) to enable fluorescence viewing. These are
typical localization patterns observed under the hrd-1 mutation.
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Figure 11. Representative images (n=12) of hrdl-1 mutant gravid adult animals in the ODR10::GFP background. Images taken on Leica DMi6000 at 400X total magnification. Contrast and
brightness are both adjusted to +20% (in PowerPoint) to enable fluorescence viewing. These are
typical localization patterns observed under the hrdl-1 mutation.
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Figure 12. Representative images (n=12) of marc-6 mutant gravid adult animals in the ODR10::GFP background. Images taken on Leica DMi6000 at 400X total magnification. Contrast and
brightness are both adjusted to +20% (in PowerPoint) to enable fluorescence viewing. These are
typical localization patterns observed under the marc-6 mutation.
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Figure 13. Representative images (n=12) of ubc-6 mutant gravid adult animals in the ODR10::GFP background. Images taken on Leica DMi6000 at 400X total magnification. Contrast and
brightness are both adjusted to +20% (in PowerPoint) to enable fluorescence viewing. These are
typical localization patterns observed under the ubc-6 mutation.
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Figure 14. Representative images (n=12) of ubc-7 mutant gravid adult animals in the ODR10::GFP background. Images taken on Leica DMi6000 at 400X total magnification. Contrast and
brightness are both adjusted to +20% (in PowerPoint) to enable fluorescence viewing. These are
typical localization patterns observed under the ubc-7 mutation.
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WT

Figure 15. Box and whisker plot representing quantitative analysis of ciliary fluorescence
intensity (arbitrary units) of animals in the ODR-10::GFP background. Strains analyzed were
wild type (kyIs53), hrd-1, hrdl-1, marc-6, ubc-6, and ubc-7. 20 adult gravid worms were
randomly selected and imaged per strain on the Leica DMi6000 and quantified via ImageJ
analysis. If no fluorescence was visible the value given was 0 for that animal. White dots indicate
outliers and error bars represent standard deviation. ** = p<0.05 and *** = p<0.005 in
comparison to wild type with Tukey’s HSD test.
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Figure 16. Box and whisker plot of chemotaxis index based on the behavioral phenotype for
chemoattraction to diacetyl, the ligand for ODR-10. Negative control was 95% ethanol. White
dots indicate outliers. Strains analyzed are wild type (n=17), odr-10 knockout (n=11), hrd-1
tm1743 (n=11), hrdl-1 gk28 (n=10), and marc-6 gk121047 (n=11), ubc-6 (n=10), and ubc-7
(n=10). *** = p<0.005 in comparison to wild type with Tukey’s HSD test.
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Figure 17. Fluorescent images of UBC-6::GFP transgenic animals at 400X total magnification.
Images taken with a Leica DMi6000. Pttx3::dsRed was co-injected with the plasmid construct
Podr-10::UBC-6::GFP as an injection control. GFP fluorescence indicates UBC-6 protein
localization at the AWA cell body indicated by the white arrow. Images are merged to indicate
cell body fluorescence is not dsRed. UBC-6::GFP fluorescence observed in animals at the adult,
L3, and L2 stages in development. Brightness and contrast were adjusted in each image to enable
viewing of cell body expression.
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Figure 18. Fluorescent images of UBC-7::GFP transgenic animals at 400X total magnification.
Images taken with a Leica DMi6000. Pttx3::dsRed was co-injected with the plasmid construct
Podr-10::UBC-7::GFP as an injection control. GFP fluorescence indicates UBC-7 protein
localization at the AWA cell body indicated by the white arrow. Images are merged to indicate
cell body fluorescence is not dsRed. UBC-7::GFP fluorescence observed in animals at the adult,
L4, and L2 stages in development. Brightness and contrast were adjusted in each image to enable
viewing of cell body expression.

	
  

	
  
70	
  

	
  

	
  

Figure 19. Our findings support a proposed ERAD ubiquitination model from yeast. 1) E3 ligase
targets and binds to misfolded ODR-10 at the ER membrane. 2) UBC-6 primes the misfolded
ODR-10 by adding one ubiquitin. UBC-7 is able to compensate for this role is UBC-6 is absent.
3) Once monoubiquitinated, UBC-7 adds another ubiquitin to the misfolded ODR-10. 4) UBC-7
will repeat this step creating a polyubiquitin chain until the necessary number of ubiquitins is
attached for degradation signaling. 5) The polyubiquitinated misfolded ODR-10 is removed from
the ER into the cytosol. 6) The 26S proteasome degrades the misfolded ODR-10 protein. (Weber
et al., 2016)
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